
Bioengineering and Medical Imaging Programme
A.1.1 Medical images
A.1.2 Biomedical signals
A.1.3 Morphological and functional modelling of tissues and organs.
A.1.4 Pre-operative and intra-operative planning as, well as creation of virtual surgery programs.
A.2.1 Creation of systems to monitor and control patients (sensoring, controlling and robotic systems)
A.2.2 Software applications to improve systems for patient diagnosis, monitoring or treatment
A.2.3 E-health and M-health Systems.
A.2.4 Artificial Intelligence applied to biomedical systems
Biomaterials and Advanced Therapies Programme
B.1.1 Biomaterials for scaffolds
B.1.2 Controlled release
B.1.3 Bioactive nanoparticles
B.1.4 Cell-biomaterial interactions
B.1.5 Advanced manufacturing techniques (electrospinning, 3D/4D bioprinting,...)
B.2.1 Cell therapy
B.2.2 Gene therapy
B.2.3 Tissue engineering
B.2.4 Stem cell differentiation and organoid culture
B.2.5 Directed genome edition
B.3. Nanobiotechnology
C.1.1 Biosensor devices based on micro/nanotechnologies to detect specific biomarkers of disease.
C.1.2 Imaging contrast agents
C.1.3 Precision personalized medicine
C.2.1 Biomolecules (enzymes, proteins, nucleic acids, antibodies, etc) and biomolecule-based conjugates as therapeutic agents and in applications for diagnosis.
C.2.2 Advanced nanoparticles for the delivery of drugs and biomolecules.
C.2.3 Pharmacokinetics and pharmacodynamic studies of therapeutic agents.
C.2.4. Theranostic systems.
C.3.1 Biocompatibility and toxicity studies of therapeutic agents.
C.3.2 Biological processes research (physiology, cell adhesion or communication, cell biophysics and epigenetic) and development of techniques for their study.